Gyala, Therapeutics

Gyala Therapeutics inicia un ensayo clínico de fase I/ IIa de una terapia con células CAR-T

Veröffentlicht: 18.03.2026 um 01:47 Uhr, prnewswire.co.uk

Gyala Therapeutics Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

en | boerse | 68765543 |